Search results for "Host Microbial Interactions"

showing 6 items of 16 documents

The intestinal 3M (microbiota, metabolism, metabolome) zeitgeist – from fundamentals to future challenges

2021

The role of the intestine in human health and disease has historically been neglected and was mostly attributed to digestive and absorptive functions. In the past two decades, however, discoveries related to human nutrition and intestinal host-microbe reciprocal interaction have established the essential role of intestinal health in the pathogenesis of chronic diseases and the overall wellbeing. That transfer of gut microbiota could be a means of disease phenotype transfer has revolutionized our understanding of chronic disease pathogenesis. This narrative review highlights the major concepts related to intestinal microbiota, metabolism, and metabolome (3M) that have facilitated our fundame…

Host Microbial InteractionsbiologyMicrobiotaDiseaseGut florabiology.organism_classificationBioinformaticsBiochemistryGastrointestinal MicrobiomeIntestinesHuman healthChronic diseasePhysiology (medical)MetabolomeMetabolomeHumansNarrative reviewDietary PhytochemicalsZeitgeistFree Radical Biology and Medicine
researchProduct

Unique Microbial Catabolic Pathway for the Human Core N-Glycan Constituent Fucosyl-α-1,6-N-Acetylglucosamine-Asparagine

2020

The survival of commensal bacteria in the human gut partially depends on their ability to metabolize host-derived molecules. The use of the glycosidic moiety of N-glycoproteins by bacteria has been reported, but the role of N-glycopeptides or glycoamino acids as the substrates for bacterial growth has not been evaluated. We have identified in Lactobacillus casei strain BL23 a gene cluster (alf-2) involved in the catabolism of the glycoamino acid fucosyl-α-1,6-N-GlcNAc-Asn (6′FN-Asn), a constituent of the core-fucosylated structures of mammalian N-glycoproteins. The cluster consists of the genes alfHC, encoding a major facilitator superfamily (MFS) permease and the α-l-fucosidase AlfC, and t…

Lactobacillus caseiGlycanMolecular Biology and Physiologyalpha-l-fucosidaseGlycosylasparaginaseMicrobiologiacore fucosylationGut floraMicrobiologydigestive systemFucosylated Nglycopeptideschemistry.chemical_compoundVirologyfucosylated N-glycopeptidesN-AcetylglucosamineHumansAsparagineSymbiosisFucosebiologyHost Microbial InteractionsChemistryProbioticsbiology.organism_classificationMajor facilitator superfamilyQR1-502LactobacilsglycosylasparaginaseCore fucosylationGastrointestinal TractMetabolic pathwayLacticaseibacillus caseiBiochemistryAlpha-L-fucosidaseMultigene Familybiology.proteinAsparagineLactobacillus caseiBacteriaMetabolic Networks and PathwaysResearch Article
researchProduct

The Microbiota: A Microbial Ecosystem Built on Mutualism Prevails

2019

Mutualism (biology)Microbial ecosystemHost Microbial InteractionsEcologyMicrobiotaAnimalsHumansImmunology and AllergyBiologySymbiosisIntroductory Journal ArticleJournal of Innate Immunity
researchProduct

The role of gut micorbiome in obesity and diabetes

2019

Background Obesity and diabetes became a grooving problem in both adults and children. Many hypotheses concerned agents involved in the excessive weight gain process and it’s consequences. Not only genetic or environmental factors, but also intestinal microbiome seems to play a role in the pathophysiology of this phenomenon. Data sources A systematic review was conducted using Pubmed as the medical database source. Studies concerning connection between microbiome and metabolic disorders such as obesity and diabetes from last 10 years were analyzed. Results Intestinal bacteria may be involved both in the development of obesity, and its further complications. The pro-infammatory and immunomod…

Psychological interventionBioinformaticslaw.invention03 medical and health sciencesProbiotic0302 clinical medicineInsulin resistancelaw030225 pediatricsDiabetes mellitusDiabetes MellitusMedicineHumans030212 general & internal medicineMicrobiomeObesityHost Microbial Interactionsbusiness.industryDiabetesmedicine.diseaseObesityGastrointestinal MicrobiomePediatrics Perinatology and Child HealthCarbohydrate Metabolism DisorderDysbiosisDisease SusceptibilityMicrobiomebusinessDysbiosisWorld Journal of Pediatrics
researchProduct

Rodent host population dynamics drive zoonotic Lyme Borreliosis and Orthohantavirus infections in humans in Northern Europe

2021

Zoonotic diseases, caused by pathogens transmitted between other vertebrate animals and humans, pose a major risk to human health. Rodents are important reservoir hosts for many zoonotic pathogens, and rodent population dynamics affect the infection dynamics of rodent-borne diseases, such as diseases caused by hantaviruses. However, the role of rodent population dynamics in determining the infection dynamics of rodent-associated tick-borne diseases, such as Lyme borreliosis (LB), caused by Borrelia burgdorferi sensu lato bacteria, have gained limited attention in Northern Europe, despite the multiannual abundance fluctuations, the so-called vole cycles, that characterise rodent population d…

jyrsijätSciencePopulation DynamicsDiseaseszoonoositinfektiotModels BiologicalPuumala virusArticlePuumala-virusZoonosesLymen borrelioosiisäntäeläimetAnimalsHumansFinlandDisease ReservoirsLyme DiseaseEcologyHost Microbial InteractionsIxodesArvicolinaeIncidenceQRpopulaatiodynamiikkaBorrelia-bakteerittaudinaiheuttajatborrelioosiHemorrhagic Fever with Renal SyndromeLinear ModelsMedicineArachnid VectorsScientific Reports
researchProduct

Immune responses during COVID-19 infection

2020

International audience; Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV (SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and 2015, and SARS-CoV-2 in 2020, have been causing severe and fatal human epidemics. The unpredictability of coronavirus disease-19 (COVID-19) poses a major burden on health care and economic systems across the world. This is caused by the paucity of in-depth knowledge of the risk factors for severe COVID-19, insufficient diagnostic tools for the detection of SARS-CoV-2, as well as the absence of specific and effective drug treatments. While protective humoral and cellular immune responses are usually m…

virusesReviewmedicine.disease_causeDiagnostic toolsSeverity of Illness Index[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunityimmune responsehumoral0302 clinical medicineRisk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesImmunology and AllergyRC254-282Coronavirus[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseasesImmunity Cellular[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseasesNeoplasms. Tumors. Oncology. Including cancer and carcinogensvirus diseases3. Good healthOncologySevere acute respiratory syndrome-related coronavirus[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology030220 oncology & carcinogenesis[SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunologyMiddle East Respiratory Syndrome Coronavirus[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesCovid-19Coronavirus disease 2019 (COVID-19)Sars-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immunology03 medical and health sciencesImmune systemIntensive caremedicineHumans[SDV.IMM.II] Life Sciences [q-bio]/Immunology/Innate immunityHost Microbial Interactionsbusiness.industryRC581-607Protective Factorsbiochemical phenomena metabolism and nutritionmedicine.diseaseimmunityImmunity HumoralClinical trialCoronavirusImmunologyMiddle East respiratory syndromeImmunologic diseases. Allergybusinesscellular030215 immunology
researchProduct